---
title: Precise pathological classification of non-small cell lung adenocarcinoma and
  squamous carcinoma based on an integrated platform of targeted metabolome and lipidome
date: '2021-11-03'
linkTitle: http://link.springer.com/10.1007/s11306-021-01849-5
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Non-small
  cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide.
  Lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most common
  subtypes of NSCLC. Despite genetic differences between LUAD and LUSC have been clarified
  in depth, the metabolic differences of these two subtypes are still unclear.</p>
  </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Methods</h3>
  ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. Lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most common subtypes of NSCLC. Despite genetic differences between LUAD and LUSC have been clarified in depth, the metabolic differences of these two subtypes are still unclear.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Methods</h3> ...